Bharat Biotech To Launch Coronavirus Vaccine By August 15th:- The Indian Council of Medical Research (ICMR) and Bharat Biotech International Limited (BBIL) are working together for a possible vaccine for the deadly coronavirus. Bharat Biotech already announced that the first and second phase of human clinical trials will start in July. Now Bharat Biotech and ICMR made it clear that the launch of vaccines for coronavirus would be possible by August 15th. The vaccine would be launched after the clinical trials are done. Bharat Biotech and ICMR developed this indigenous coronavirus vaccine (BBV152 COVID vaccine).
Twelve institutes are selected to conduct the clinical trials in the country. The ICMR made it clear to launch the vaccine in the country at the earliest considering the public health and safety. Fast track clinical trials will be conducted for the vaccine on a priority basis. Bharat Biotech is working to meet the deadline and the final output depends completely on the clinical trial sites involved. Bharat Biotech developed Covaxin in association with ICMR and National Institute of Virology (NIV). It is developed in Biotech’s BSL-3 (Bio-Safety Level 3) High Containment facility in Hyderabad's Genome Valley.
The Drug Controller General of India- Central Drugs Standard Control Organisation and Ministry of Health & Family Welfare already granted permissions for the human clinical trials.
(Video Source: India Today)
